Athiras lead clinical candidate, fosgonimeton (formerly ATH-1017 / NDX-1017), is a structurally distinct phosphate prodrug of Dihexa not Dihexa itself
Those who are pregnant, nursing, or taking medications should consult a healthcare professional before use to ensure safety and appropriate dosing.
Accessed 12 May 2021 Leung DTM, Tam FCH, Chun HM et al (2004) Antibody response of patients with Severe Acute Respiratory Syndrome (SARS) targets the viral nucleocapsid
The SURMOUNT-4 trial specifically studied what happens when tirzepatide treatment stops after significant weight loss
We offer Vitamin B12 injections to boost energy, improve focus, and promote longevity
The new age skin rejuvenation formula offers an all rounder approach to skin boosting and wrinkle firming via GHK-Cu supporting a healthy skin renewal process compounded with hyaluronic acid to assist in deep hydration delivery and water soluble actives through its non equilibrium structure